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1 
 
GENERAL INTRODUCTION 
 
Organic chemistry has always rewarded creativity and innovation whether it is in 
developing new synthetic strategies or novel laboratory techniques. Over the past several 
decades, organic synthesis has flourished with the accrual of useful synthetic methodologies 
and total syntheses of complex organic molecules. Interdisciplinary research has been a forte 
of organic chemistry. In collaboration with biology and medicinal chemistry, it has led to 
discovery and the ensuing syntheses of biologically potent natural products, which have been 
translated into drug applications. For pharmaceutical applications, readily makeable 
biologically active molecules are best suited. To meet that end, concise syntheses have been 
highly desirable and sought after. 
In this context, we explored direct routes to several biologically significant natural 
products. In course of the syntheses, novel synthetic methodologies were developed. These 
studies will be helpful to design approaches to other structurally related natural products. 
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CHAPTER 1: SYNTHESIS OF BENZOXEPIN SKELETON VIA A RING-CLOSING 
METATHESIS REACTION 
  
Introduction 
 Among the recently isolated natural products, which possess a benzoxepin skeleton, 
are tournefolic acid B, its ethyl ester and bauhiniastatins (1-4) (Figure 1). Tournefolic acid B 
and its ethyl ester have been obtained from Tournefortia sarmentosa, which is used in Taiwan 
as a detoxicant, an anti-inflammatory agent and for promoting blood circulation for removal 
of blood stasis.
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Figure 1 
Bauhiniastatins 1-4 have been obtained from Bauhinia purpurea, a well known 
ornamental tree in Taiwan. Careful chemical studies of the heartwood
2
 and bark
3
 led to 
isolation of 27 components, which included a chromone, carbohydrates, flavonoids, lipids, 
phenols, steroids, and triterpenes.
4
 Traditional use of B. purpurea in sub-Himalayan regions 
of India point to gastrointestinal activities with applications as a laxative (flowers),
5
 a 
3 
 
carminative drug (roots) and for diarrhea (bark).
6
 A novel flavone rhamnopyranoside has 
been isolated from this source
6
 and there is an earlier evidence for a chalcone glycoside 
component.
7
 Other chemical investigations of B. purpurea components have been related to 
flavonoids
8
 such as the hypoglycemic and antioxidant kaempferol dirhamnoside from B. 
forficata, a conventional antidiabetic treatment in Brazil,
9
 and earlier with hypoglycemic 
flavonoid-containing fractions from leaves of B. purpurea grown in Egypt.
10
 Currently, B. 
purpurea seems best known for a lectin agglutinin that binds to dense cell surface 
glycoconjugates and could be of use in medical applications.
11 
Bauhiniastatins 1-4 are 
reported to exhibit significant growth inhibition against a minipanel of human cancer cell 
lines and bauhiniastatin 1 was also found to inhibit the P388 cancer cell line.
4
 
Searching through the literature provided three examples to make the benzoxepin 
skeleton. The first one involved acid-catalyzed rearrangement of xanthene-9-carbinol to yield 
the product (Scheme 1).
12
 The second one entailed displacement of one nitro group followed 
by cyclization and dehydration (Scheme 2).
13
 The third one used a diphosphorane to make the 
benzoxepin core structure (Scheme 3).
14
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Results and Discussion 
As shown in the retrosynthetic analysis, we envisioned that the benzoxepin core unit 1 
could be assembled via cyclization of compound 2 using the phosphazine base P4-t-Bu (5). 
Compound 2 could be prepared by the SNAr reaction of 3 and 4 (Scheme 4).  
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5  
Kraus and co-workers have employed P4-t-Bu (5) to synthesize phenanthrenes.
15
 In 
the synthesis of tetrangulol, P4-t-Bu cyclization was used to obtain a key phenanthrene 
intermediate (Scheme 5).
16 
In another application, Kraus and co-workers used P4-t-Bu to 
prepare benzofurans from ortho-substituted benzaldehydes (Scheme 6).
17 
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Scheme 6 
Towards the synthesis of 1, 2,5-dihydroxy benzaldehyde was brominated using 
bromine in chloroform to afford compound 6 in 92% yield.
18
 Diol 6 was methylated using 
dimethyl sulfate and potassium carbonate in acetone to furnish the dimethoxy compound 3 in 
60% yield (Scheme 7). The other coupling partner 4 was synthesized from 2-methyl 
resorcinol (7) using sodium hydroxide and dimethyl sulfate in water in 77 % yield based on 
recovered starting material (Scheme 8).
19 
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 First, we attempted to couple compounds 3 and 4 under standard Ulmann conditions 
using potassium carbonate and copper(II) oxide in pyridine (Scheme 9).
20
 This just returned 
the starting materials. 
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Scheme 9 
 We then employed a modified procedure for Ulmann coupling using cesium 
carbonate, copper(I) chloride and 2,2,6,6-tetramethyl-3,5-heptanedione as the ligand in N-
methylpyrrolidone (Scheme 10).
21 
Unfortunately, it gave a complex mixture. 
OMe
OMe
CHO
Br HO
Me
OMe
Cs2CO3, CuCl
complex mixture
O O
43 NMP, 120 °C  
Scheme 10 
 At this stage, we decided to change the halogen atom in 3 from bromine to fluorine. 
The underlying rationale was to enhance the SNAr reaction by reducing the size of the 
halogen atom. To that end, 2,5-dimethoxy-6-fluorobenzaldehyde (9) was prepared from 2,5-
dimethoxybenzaldehyde (8) using n-BuLi and N,N-dimethylformamide (Scheme 11).
22
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Pleasingly, the SNAr reaction of phenol 4 with aldehyde 9 using potassium carbonate 
in N,N-dimethylacetamide provided diphenylether 2 in 51% isolated yield (Scheme 12).
23
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 However, to our dismay, the crucial P4-t-Bu cyclization reaction returned the starting 
materials when boiled in benzene (Scheme 13).
17
 When toluene was used as the solvent, 
instead of getting the product, we observed loss of aldehyde functionality (Scheme 14). 
Perhaps, P4-t-Bu deprotonated the more acidic methyl group on toluene, which attacked the 
aldehyde group intermolecularly to cleave the carbon-carbon bond (Scheme 15). 
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Scheme 14 
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At this juncture, we attempted brominating the aromatic methyl group in 2 to try the 
intramolecular Grignard reaction. Unfortunately, the bromination gave multiple products, 
which were hard to separate from each other using column chromatography (Scheme 16). 
Presumably, ring bromination might have competed with desired bromination of the aromatic 
methyl group. 
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Scheme 16 
We redesigned our strategy and tried to apply the McMurry coupling to get the 
benzoxepin skeleton. To obtain the requisite precursor 13, we coupled the dimethoxy 
compound 9 with phenol 12 to get the dialdehyde 13 in 31% yield. The stage was now set for 
us to try the key McMurry coupling. Upon treatment of dialdehyde 13 with zinc and titanium 
tetrachloride in tetrahydrofuran under microwave conditions, benzoxepin 1 was obtained, 
although in an unsatisfactory 8% yield (Scheme 17).
24
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 Scheme 17 
 In pursuit of developing an improved method, we planned to use ring closing 
metathesis (RCM) to attain the bauhinoxepin skeleton. To that end, we converted the 
dialdehyde 13 into the divinyl compound 14 using Wittig olefination.
25
 The ring-closing 
metathesis reaction, however, returned the starting material (Scheme 18). 
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Scheme 18 
We speculated that non-bonded interactions might have played a significant part in 
failure of the RCM. Upon extensively searching the literature, we found that there were no 
examples of RCM where all positions ortho to the vinyl groups were substituted.
26,27 
To test 
our hypothesis, we decided to synthesize 15 (Figure 2).  
O
OMe
H
15  
Figure 2 
To prepare the desired precursor 15, we coupled 3-methoxy-2-vinylphenol (16) with 
2-fluorobenzaldehyde (17) using cesium carbonate in boiling N,N-dimethylacetamide to 
10 
 
provide diphenylether 18. Wittig olefination of aldehyde 18 furnished the divinyl compound 
15.
25
 To our delight, the ring-closing metathesis reaction of 15 using 10 mole percent of 
Grubbs 2
nd
 generation catalyst in boiling dichloromethane gave the desired benzoxepin 19 in 
39% yield (59% based on recovered starting material) (Scheme 19).
26,27 
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Scheme 19 
 
Encouraged by the success of RCM, we focused on making tournefolic acid B and its 
ethyl ester. As shown in the retrosynthetic analysis, we visualized making tournefolic acid B 
from its ethyl ester, which in turn could be assembled via a ring-closing metathesis (RCM) 
and a Heck reaction. Divinyl compound 20 could be made from 6-fluoroveratraldehyde (21) 
and 6-bromo-2-hydroxy-3-methoxybenzaldehyde (22) (Scheme 20). 
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Wittig olefination of aldehyde 22 provided the vinyl compound 23 in 89% yield 
(Scheme 21). At this point, we were faced with the challenge of forming the C-O bond. Even 
extensive searching through the literature did not provide us with relevant examples in which 
both the electronic and the steric factors were unfavorable for the SNAr reaction. The phenol 
23 is quite hindered whereas 6-fluoroveratraldehyde (21) has two strong electron donating 
groups on the phenyl ring. 
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22 23  
Scheme 21  
To proceed with our plan, we attempted to form the C-O bond using a variety of 
different conditions. We used potassium fluoride-alumina or cesium carbonate as the base. 
We changed the solvents and tried dimethyl sulfoxide, N,N-dimethylacetamide, N,N-
dimethylformamide, acetonitrile and 1,4-dioxane. We also subjected the reaction to different 
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heating conditions, like heating in an oil bath, as well as in a microwave (Scheme 22, Table 
1). To our dismay, none of the above combinations gave us the desired adduct 24 (Table 1).   
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Scheme 22 
Solvent Outcome 
N,N-dimethylacetamide decomposition 
N,N-dimethylformamide decomposition 
acetonitrile no reaction 
1,4-dioxane no reaction 
Table 1 
 
Changing the coupling partner to 6-bromoveratraldehyde (25) did not help either 
(Scheme 23). Using 2-bromo-4,5-dimethoxybenzoic acid  (26) as the coupling partner with 
compound 23 was equally ineffective (Scheme 24).
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Scheme 24 
To form the elusive C-O bond, we introduced a nitro group at the position ortho to the 
halogen atom. Nitration of dimethoxy compound 28 afforded the nitro compound 29 in 91% 
yield (Scheme 25).
28
 Subjecting the coupling reaction of 23 with 29 to comparatively mild 
conditions gave back the starting materials. Exposing the reaction to harsh microwave 
conditions led to decomposition (Scheme 26). 
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Scheme 26 
In a different route to form the C-O bond, we also tried coupling the substituted 
phenol 23 with boronic acid 31, prepared from 6-bromoveratraldehyde (25) in two steps 
(Scheme 27).
29
 The modified Ulmann conditions, however, gave a complex mixture of 
products (Scheme 28).
30,31
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Conclusion 
 In summary, we have developed a novel method for building the benzoxepin skeleton, 
which entailed use of ring-closing metathesis reaction as the key step. Although, our efforts 
were impeded by not being able to form the C-O bond, we are currently targeting other 
15 
 
natural products with the same core structure wherein the C-O bond would be easily 
makeable. 
 
Experimental Section 
 Unless otherwise noted, materials were obtained from commercial suppliers and used 
without purification. All experiments were performed under argon atmosphere unless 
otherwise noted. Nuclear magnetic resonance experiments were performed with either a 
Varian 300 MHz or a Varian 400 MHz instrument. All chemical shifts are reported relative to 
CDCl3 (7.27 ppm for 
1
H NMR and 77.23 ppm for 
13
C NMR) unless otherwise noted. 
Coupling constants (J) are reported in Hz with abbreviations: s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet. High resolution mass spectra were recorded on a Kratos 
model MS-50 spectrometer and low resolution mass spectra were performed with a Finnegan 
TSQ700 mass spectrometer. Standard grade silica gel (60 A, 32-63 µm) was used for flash 
column chromatography. 
 
Compound 1 
To zinc dust (20 mg, 0.31 mmol) in tetrahydrofuran (1 mL) were added titanium 
tetrachloride (0.02 ml, 0.16 mmol) and dialdehyde 13 (41 mg, 0.13 mmol) in tetrahydrofuran 
(0.5 mL) in a microwave vial. After heating in the microwave for 1 h at 20 W power, the 
reaction mixture was poured into water and extracted with diethyl ether. The organic layer 
was dried over magnesium sulfate, passed through a pad of basic alumina and then 
evaporated in vacuo. The residue was purified using preparative TLC (hexanes : ethyl acetate 
16 
 
= 3:1) to afford the cyclized compound 1 (3 mg, 8%).
1
H NMR (400 MHz, CDCl3) δ 7.22-
7.26 (m, 1H), 7.03-7.12 (m, 2H), 6.97 (d, 1H, J = 8.4 Hz), 6.86 (d, 1H, J = 8.8 Hz), 6.67 (d, 
1H, J = 8.4 Hz), 6.57 (d, 1H, J = 8.8 Hz), 3.89 (s, 3H), 3.83 (s, 3H), 3.79 (s, 3H); LRMS (EI): 
m/z 284 (M
+
, 100%), 269, 254, 241. 
 
Compound 2 
To a stirred solution of 4 (190 mg, 1.36 mmol) in N,N-dimethylacetamide (7 mL) 
were added potassium carbonate (190 mg, 1.36 mmol) and 9 (250 mg, 1.36 mmol) in N,N-
dimethylacetamide (6 mL) at rt. After heating to reflux for 16 h, the reaction mixture was 
cooled to rt, diluted with ethyl acetate and washed with water and brine, successively. The 
organic layer was dried over magnesium sulfate, filtered and evaporated in vacuo. The 
residue was purified by flash column chromatography on silica gel (hexanes : ethyl acetate = 
4:1) to afford the diphenylether 2 (210 mg, 51%).
1
H NMR (300 MHz, CDCl3) δ 10.31 (s, 
1H), 7.19 (d, 1H, J = 9.3 Hz), 6.91-6.98 (m, 1H), 6.81 (d, 1H, J = 9.3 Hz), 6.56 (d, 1H, J = 
8.1 Hz), 6.06 (d, 1H, J = 8.4 Hz), 3.91 (s, 3H), 3.86 (s, 3H), 3.72 (s, 3H), 2.31 (s, 3H). 
 
Compound 3 
To a stirred solution of 6-bromo-2,5-dihydroxybenzaldehyde (6) (0.5 g, 2.3 mmol) in 
acetone (6 mL) was added potassium carbonate (0.95 g, 6.9 mmol) at rt. After stirring for 30 
min at rt, was added dimethyl sulfate (0.55 mL, 5.75 mmol) and the stirring continued for 20 
h upon which the reaction mixture was passed through a pad of Celite and evaporated in 
vacuo. The residue was purified by flash column chromatography on silica gel (hexanes : 
17 
 
ethyl acetate = 9:1 to 7:3) to afford the dimethoxy compound 3
29
 (0.3 g, 54%) as a white 
solid: mp 99-101 
°
C;
 1
H NMR (400 MHz, CDCl3) δ  10.42 (s, 1H), 7.08 (d, 1H, J = 8.8 Hz), 
6.94 (d, 1H, J = 9.2 Hz), 3.90 (s, 3H), 3.88 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 191.1, 
155.6, 150.6, 124.9, 117.3, 115.0, 111.6, 57.4, 56.8. 
 
Compound 4 
To a stirred solution of 2-methylresorcinol 7 (1 g, 8.1 mmol) in water (5 mL) were 
added sodium hydroxide (0.32 g, 8.1 mmol) and dimethyl sulfate (0.77 mL, 8.1 mmol) at rt. 
After refluxing for 8.5 h, the reaction mixture was cooled to rt and additional sodium 
hydroxide (0.32 g, 8.1 mmol) was added to it. The resulting solution was diluted with diethyl 
ether and the aqueous layer developed was acidified with aqueous 4 N hydrochloric acid. 
This acidified aqueous layer was then extracted with diethyl ether and washed with water and 
brine, successively. The organic layer was dried over magnesium sulfate, filtered and 
evaporated in vacuo. The residue was purified by flash column chromatography on silica gel 
(hexanes : ethyl acetate = 4:1) to afford 4
17
 (0.43 g, 40%, 77% based on recovered starting 
material).
 1
H NMR (400 MHz, CDCl3) δ  7.04 (t, 1H, J = 8.1 Hz), 6.48 (t, 2H, J = 7.5 Hz), 
4.67 (s, 1H), 3.83 (s, 3H), 2.13 (s, 3H). 
 
Compound 6 
To a solution of 2,5-dihydroxybenzaldehyde (0.69 g, 5  mmol) in chloroform (20 mL) 
stirred for 2 h, was added bromine (0.28 mL, 5.5 mmol) in chloroform (10 mL) at rt. After 
stirring the reaction mixture for 5 h at rt, saturated aqueous sodium thiosulfate solution was 
18 
 
added to consume the excess bromine. The resulting solution was diluted with 
dichloromethane, washed with water and brine, successively. The organic layer was dried 
over magnesium sulfate, filtered and evaporated in vacuo. The residue was purified by flash 
column chromatography on silica gel (hexanes : ethyl acetate = 4:1) to afford 6 (1 g, 92%).
1
H 
NMR (400 MHz, CDCl3) δ  11.65 (s, 1H), 10.27 (s, 1H), 7.24 (d, 1H, J = 9.2 Hz), 6.8 (d, 1H, 
J = 9.2 Hz), 5.36 (s, 1H). 
 
Compound 9 
To a stirred solution of 2-fluoro-1,4-dimethoxybenzene (8) (1 g, 6.41 mmol) in 
tetrahydrofuran (40 mL) was added n-BuLi (2.5 M solution in hexanes, 2.6 mL, 6.41 mmol) 
at -78 
°
C. After 1 h at the same temperature, N,N-dimethylformamide (1 mL, 12.82 mmol) 
was added to it and the reaction was continued to stir for 35 min at the same temperature 
upon which it was quenched with glacial acetic acid in tetrahydrofuran at -78 
°
C. After 
warming to room temperature, the resulting solution was diluted with diethyl ether and 
washed with water and brine, successively. The organic layer was dried over magnesium 
sulfate, filtered and evaporated in vacuo. The residue was purified by flash column 
chromatography on silica gel (hexanes : ethyl acetate = 2:1) to afford aldehyde 9 (1 g, 
88%).
1
H NMR (400 MHz, CDCl3) δ  10.44 (d, 1H, J = 1.2 Hz), 7.16 (t, 1H, J = 9.2 Hz), 6.69 
(dd, 1H, J = 9.2 Hz, 2.0 Hz), 3.90 (s, 3H), 3.88 (s, 3H). 
 
Compound 13 
19 
 
To a stirred solution of 12 (87 mg, 0.57 mmol) in N,N-dimethylacetamide (5 mL) 
were added potassium carbonate (79 mg, 0.57 mmol) and 9 (100 mg, 0.54 mmol) in a 
microwave vial. After subjecting the reaction mixture to microwave heating for 5 h at 165 
°
C, 
it was cooled to rt, diluted with ethyl acetate and washed with water and brine, successively. 
The organic layer was dried over magnesium sulfate, filtered and evaporated in vacuo. The 
residue was purified by flash column chromatography on silica gel (hexanes : ethyl acetate = 
1:1) to afford the dialdehyde 13 (53 mg, 31%).
1
H NMR (400 MHz, CDCl3) δ  10.70 (s, 1H), 
10.36 (s, 1H), 7.25-7.31 (m, 2H), 7.20 (d, 1H, J = 9.2 Hz), 6.85 (d, 1H, J = 9.2 Hz), 6.63 (d, 
1H, J = 8.4 Hz), 6.13 (d, 1H, J = 8.4 Hz), 3.94 (s, 3H), 3.92 (s, 3H), 3.73 (s, 3H). 
 
Compound 14 
To a stirred solution of the methyltriphenylphosphonium iodide (193 mg, 0.48 mmol) 
in tetrahydrofuran (3 mL) was added sodium bis(trimethylsilyl)amide (97 mg, 0.53 mmol) in 
tetrahydrofuran (3 mL). After 3 h at rt, the solution was cooled to – 78 
°
C, 13 (54 mg, 0.17 
mmol) in tetrahydrofuran (4 mL) was added to it and the reaction mixture was allowed to 
warm gradually to rt and stirred overnight. The reaction was quenched with saturated aqueous 
ammonium chloride solution and the resulting solution was diluted with diethyl ether, 
washed with water and brine, successively. The organic layer was dried over magnesium 
sulfate, filtered and evaporated in vacuo. The residue was purified by flash column 
chromatography on silica gel (hexanes : ethyl acetate = 6:1) to afford the divinyl compound 
14 (26 mg, 50%).
1
H NMR (400 MHz, CDCl3) δ  7.11-7.20 (m, 1H), 6.97 (t, 1H, J = 8.4 Hz), 
6.86 (d, 1H, J = 8.8 Hz), 6.71-6.80 (m, 2H), 6.56 (d, 1H, J = 8.4 Hz), 6.22 (dd, 1H, J = 18 
20 
 
Hz, 2.8 Hz), 6.02-6.10 (m, 2H), 5.54 (dd, 1H, J = 12.4 Hz, 2.8 Hz), 5.38 (dd, 1H, J = 12.0 
Hz, 2.4 Hz), 3.89 (s, 3H), 3.86 (s, 3H), 3.68 (s, 3H). 
 
Compound 15 
To a stirred solution of the methyltriphenylphosphonium iodide (130 mg, 0.33 mmol) 
in tetrahydrofuran (10 mL) was added sodium bis(trimethylsilyl)amide (55 mg, 0.3 mmol) in 
tetrahydrofuran (5 mL). After 3 h at rt, the solution was cooled to – 78 
°
C, 18 (55 mg, 0.22 
mmol) in tetrahydrofuran (5 mL) was added to it and the reaction mixture was warmed to rt 
over 1 h. The reaction was quenched with saturated aqueous ammonium chloride solution 
and the resulting solution was diluted with diethyl ether, washed with water and brine, 
successively. The organic layer was dried over magnesium sulfate, filtered and evaporated in 
vacuo. The residue was purified by flash column chromatography on silica gel (hexanes : 
ethyl acetate = 19:1) to afford the divinyl compound 15 (38 mg, 69%).
1
H NMR (300 MHz, 
CDCl3) δ  7.62 (dd, 1H, J = 7.5 Hz, 1.8 Hz), 7.17-7.25 (m, 1H), 6.94-7.15 (m, 4H), 6.81 (dd, 
1H, J = 8.1 Hz, 1.2 Hz), 6.69 (d, 1H, J = 8.1 Hz), 6.40 (d, 1H, J = 8.4 Hz), 6.15 (dd, 1H, J = 
18.0 Hz, 2.4 Hz), 5.83 (dd, 1H, J = 17.7 Hz, 1.2 Hz), 5.48 (dd, 1H, J = 12.0 Hz, 2.4 Hz), 5.30 
(dd, 1H, J = 11.4 Hz, 1.5 Hz), 3.91 (s, 3H). 
 
Compound 16 
To a stirred solution of the methyltriphenylphosphonium iodide (1.17 g, 2.9 mmol) in 
tetrahydrofuran (7 mL) was added sodium bis(trimethylsilyl)amide (0.53 g, 2.9 mmol) in 
tetrahydrofuran (3 mL). After 3 h at rt, the solution was cooled to – 78 
°
C, 12 (0.2 g, 1.3 
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mmol) in tetrahydrofuran (7 mL) was added to it and the reaction mixture was warmed to rt 
over 2 h. The reaction was quenched with saturated aqueous ammonium chloride solution 
and the resulting solution was diluted with diethyl ether, washed with water and brine, 
successively. The organic layer was dried over magnesium sulfate, filtered and evaporated in 
vacuo. The residue was purified by flash column chromatography on silica gel (hexanes : 
ethyl acetate = 9:1) to afford the vinyl compound 16 (0.16 g, 83%, 98% yield based on 
recovered starting material). 
1
H NMR (400 MHz, CDCl3) δ  7.12 (t, 1H, J = 8.4 Hz), 6.79-
6.88 (m, 1H), 6.57 (d, 1H, J = 8.4 Hz), 6.47 (d, 1H, J = 8.4 Hz), 5.72 (dd, 1H, J = 18.4 Hz, 
2.0 Hz), 5.62 (dd, 1H, J = 12.0 Hz, 2.0 Hz), 5.61 (s, 1H), 3.84 (s, 3H). 
  
Compound 18 
To a solution of 16 (150 mg, 1 mmol) in N,N-dimethylacetamide (10 mL) were added 
cesium carbonate (360 mg, 1.1 mmol), 17 (0.10 mL, 1 mmol) in N,N-dimethylacetamide (5 
mL) and the reaction mixture was heated to reflux overnight. The reaction solution was then 
diluted with diethyl ether, washed with water and brine, successively. The organic layer was 
dried over magnesium sulfate, filtered and evaporated in vacuo. The residue was purified by 
flash column chromatography on silica gel (hexanes : ethyl acetate = 4:1) to afford 
diphenylether 18 (63 mg, 25% unoptimized yield).
 1
H NMR (400 MHz, CDCl3) δ  10.57 (s, 
1H), 7.93 (dd, 1H, J = 7.6 Hz, 1.6 Hz), 7.44-7.50 (m, 1H), 7.21 (t, 1H, J = 8.4 Hz), 7.15 (t, 
1H, J = 8.4 Hz), 6.81-6.90 (m, 1H), 6.79 (d, 1H, J = 8.4 Hz), 6.76 (d, 1H, J = 8.4 Hz), 6.59 
(d, 1H, J = 8.0 Hz), 6.05 (dd, 1H, J = 17.6 Hz, 2.0 Hz), 5.45 (dd, 1H, J = 12.0 Hz, 2.4 Hz), 
3.92 (s, 3H). 
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Compound 19 
To a solution of 15 (35 mg, 0.14 mmol) in dichloromethane (10 mL) was added 
Grubbs’ 2nd generation catalyst (12 mg, 0.014 mmol). The reaction mixture was stirred for 
10 h at rt and then heated to reflux for 20 h. After cooling to rt, the reaction solution was 
passed through a pad of Celite and evaporated in vacuo. The residue was purified by 
preparative TLC (hexanes : ethyl acetate = 49:1, eluted three times) to afford the cyclized 
compound 19 (12 mg, 39%, 59% based on recovered starting material).
 1
H NMR (400 MHz, 
CDCl3) δ  7.22-7.31 (m, 2H), 7.15-7.20 (m, 2H), 7.09-7.15 (m, 1H), 7.06 (d, 1H, J = 11.6 
Hz), 6.85 (d, 1H, J = 8.4 Hz), 6.78 (d, 1H, J = 11.6 Hz), 6.68 (d, 1H, J = 8.4 Hz), 3.85 (s, 
3H); LRMS (EI): m/z 224 (M
+
), 181 (100%), 152. 
 
Compound 23 
To a stirred solution of the methyltriphenylphosphonium iodide (2.71 g, 6.71 mmol) 
in tetrahydrofuran (15 mL) was added sodium bis(trimethylsilyl)amide (1.19 g, 6.5 mmol) in 
tetrahydrofuran (10 mL). After 3 h at rt, the reaction solution was cooled to – 78 
°
C, 22 (0.5 
g, 2.16 mmol) in tetrahydrofuran (10 mL) was added to it and the reaction mixture was 
gradually warmed to rt overnight. The reaction was quenched with saturated aqueous 
ammonium chloride solution and the resulting solution was diluted with diethyl ether, 
washed with water and brine, successively. The organic layer was dried over magnesium 
sulfate, filtered and evaporated in vacuo. The residue was purified by flash column 
chromatography on silica gel (hexanes : ethyl acetate = 4:1) to afford the vinyl compound 23 
(0.44 g, 89%). 
1
H NMR (300 MHz, CDCl3) δ  7.1 (d, 1H, J = 9.0 Hz), 6.78-6.89 (m, 1H), 
23 
 
6.65 (d, 1H, J = 8.7 Hz), 6.15 (s, 1H), 6.1 (dd, 1H, J = 17.7 Hz, 1.8 Hz), 5.63 (dd, 1H, J = 
11.7 Hz, 2.1 Hz), 3.91 (s, 3H). 
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CHAPTER 2: CONCISE SYNTHESIS OF BAUHINOXEPIN J USING 
INTRAMOLECULAR RADICAL CYCLIZATION 
 
Introduction 
Bauhinoxepin J (3),
1
 a dihydrodibenzoxepin, belongs to a family of secondary 
metabolites (Figure 1) isolated from a shrubby tree, Bauhinia purpurea L. (family 
Leguminosae), commonly known as “Chong Kho” or “Siao Dok Daeng” (in Thai). This plant 
is reported to contain cytotoxic oxepins,
2
 flavone glycosides,
3
 flavanones
4
 and lectins.
5
 B. 
purpurea lectins are of significant interest and have been utilized as potential biological tools 
to bind with cellular proteins and carbohydrates.
6-8 
The genus Bauhinia has been found to be 
a rich source of bioactive metabolites,
9
 bibenzyls
9a,c
 and dibenzo[b,f]oxepins.
9b
 
Bauhinoxepin J has been reported to exhibit potent antimycobacterial activity (MIC 
24.4 µM), excellent antimalarial activity (IC50 5.8 µM) and also cytoxicity toward KB and BC 
cell lines with IC50 values of 10.5 and 12.1 µM, respectively.
1
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Figure 1 
 Bauhinoxepin J has a dihydrodibenzoxepin skeleton with a seven membered central 
ring flanked by a benzene ring on one side and a benzoquinone on the other. There have been 
two syntheses reported to make the dihydrodibenzoxepin skeleton. The first one involved 
acid-catalyzed rearrangement of xanthene-9-carbinol followed by reduction
10
 (Scheme 1). 
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The second method entailed tetrabromination of 2,2´-dimethyldiphenyl ether with N-
bromosuccinimide followed by cyclization
11
 (Scheme 2). 
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Scheme 2 
 Herein, we report an effective way to make the natural product, bauhinoxepin J 3, in 
13% overall yield starting from readily available 9 and 11 in just three steps. (Schemes 11 
and 12) The key step in the synthesis is an intramolecular decarboxylative radical addition to 
a quinone. To the best of our knowledge, there is no precedent for the intramolecular radical 
addition to a quinone to make a seven membered ring, although the intermolecular version 
has been reported.  
Kraus and coworkers have reported addition of radicals, generated by 
decarboxylation, to substituted and unsubstituted quinones
12,13
 (Schemes 3-5). Phenyliodoso 
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diacetate and the combination of ammonium persulfate in presence of catalytic silver nitrate 
have both been effectively employed to generate a radical from the carboxylic acid 
functionality. 
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Scheme 5 
 
Results and Discussion 
As shown in the retrosynthetic analysis, we envisioned that 3 could be assembled via 
the C-O bond formation followed by decarboxylative radical cyclization. This pathway 
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directed us to our starting materials: 3-(2-hydroxyphenyl)-propionic acid 4 and 2,5-
dimethoxy-1,4-benzoquinone 5 (Scheme 6). 
O
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Radical cyclization
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COOH
OMe
3 4 5  
Scheme 6 
 Due to the extremely poor solubility of 2,5-dimethoxy-1,4-benzoquinone 5 in N,N-
dimethylformamide, the C-O bond forming reaction did not work. 5 was practically insoluble 
even in other polar solvents like dimethyl sulfoxide, acetone and N,N-dimethylacetamide. 
(Scheme 7). 
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Therefore, we decided to use 2-bromo-5-methoxy-1,4-benzoquinone 9, which was 
made in two steps from 1,2,4-trimethoxybenzene 7 (Scheme 8), as the coupling partner.
14,15 
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30 
 
We screened an array of different bases to find the best conditions. Unfortunately, the 
best yield obtained (using sodium hydride as the base in N,N-dimethylformamide) was 33% 
and the reaction was not reproducible (Scheme 9). Presumably, this could be attributed to the 
poor solubility of the formed dianion. 
O
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33%
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very low to no yield!
NaH
4 9 6
 
Scheme 9 
 
To circumvent this difficulty, we decided to begin with diol 11, which was prepared 
by treating dihydrocoumarin 10 with lithium aluminum hydride
16
 (Scheme 10). We generated 
the monoanion from the diol 11 using potassium carbonate and reacted it with 9 to give the 
adduct 12 in 59% yield. The primary alcohol 12 was then oxidized to the carboxylic acid 6 
using Jones reagent in 73% yield (Scheme 11). 
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The stage was set for us to try the pivotal decarboxylative radical cyclization. First, 
we attempted to use phenyliodoso diacetate
17,18
 to generate the radical from 6. To our 
disappointment, it provided a meager 4% yield of the target compound. We employed 
Barton’s ester,
19,20
 made from the carboxylic acid, in order to get the seven membered ring. 
Unfortunately, this method did not provide any desired product. We then decided to use the 
silver (I)-catalyzed persulfate reaction.
21,22 
To our delight, ammonium persulfate with 
equivalent proportions of the silver salt afforded 3 in 30% yield for that step, which 
constitutes a 13% overall yield of bauhinoxepin J from 11 and 9. The identity of synthesized 
bauhinoxepin J (4) was confirmed by comparison of the obtained 
1
H NMR, 
13
C NMR, LRMS 
and HRMS data with the published ones. We also tried using a different counter ion, 
potassium persulfate, instead of ammonium persulfate. However, it provided only 13% yield 
of the product (Scheme 12). 
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Scheme 12 
The mechanism of silver (I)-catalyzed persulfate reaction is shown below as proposed by 
Minisci.
22a
 
(i) Generation of carbon centered radical 
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(ii) Addition to quinone 
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(iii)  Oxidation of the radical adduct in a redox chain 
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Conclusion 
 In summary, we have succesfully synthesized bauhinoxepin J using a novel 
persulfate-mediated intramolecular decarboxylative radical addition to a quinone. In our 
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effort to expand this strategy, we are currently working on making xanthones and other 
biologically important natural products. 
 
Experimental Section 
 Unless otherwise noted, materials were obtained from commercial suppliers and used 
without purification. All experiments were performed under argon atmosphere unless 
otherwise noted. Nuclear magnetic resonance experiments were performed with either a 
Varian 300 MHz or a Varian 400 MHz instrument. All chemical shifts are reported relative to 
CDCl3 (7.27 ppm for 
1
H NMR and 77.23 ppm for 
13
C NMR) unless otherwise noted. 
Coupling constants (J) are reported in Hz with abbreviations: s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet. High resolution mass spectra were recorded on a Kratos 
model MS-50 spectrometer and low resolution mass spectra were performed with a Finnegan 
TSQ700 mass spectrometer. Standard grade silica gel (60 A, 32-63 µm) was used for flash 
column chromatography. 
 
Compound 3 
To a solution of the acid 6 (16 mg, 0.05 mmol) in acetonitrile : water (1:1, 3 mL) 
were added silver nitrate (9 mg, 0.05 mmol) and ammonium persulfate at rt. After being 
heated at 70 
°
C for 5 h, the mixture was cooled to rt. The solvent was evaporated in vacuo. 
The residue was diluted with ethyl acetate and washed with water and saturated aqueous 
sodium carbonate solution, successively. The organic layer was dried over magnesium 
sulfate, filtered and evaporated under reduced pressure. The residue was purified by flash 
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column chromatography on silica gel (ethyl acetate) to afford 3 (4 mg, 30% yield). IR (thin 
film): 2915, 2849, 1661, 1607, 1582, 1488, 1463, 1380, 1228, 1193 cm
-1
 ; 
1
H NMR (400 
MHz, CDCl3) δ 7.25-7.22 (m, 2H), 7.18 (d, 1H, J = 6.8 Hz), 7.15-7.11 (m, 1H); 13C NMR 
(100 MHz , CDCl3) δ 182.8, 181.9, 158.9, 155.7, 152.9, 133.2, 129.6, 128.0, 126.0, 123.7, 
121.2, 105.4, 56.7, 29.9, 26.5; LRMS (EI): m/z 256 (M
+
, 100%), 241, 115, 69; HRMS (EI) 
calcd for C15H12O4: 256.0736, found: 256.0740. 
 
Compound 6 
To a solution of the alcohol 12 (125 mg, 0.43 mmol) in acetone (10 mL) at 0 
°
C was 
added 8N Jones reagent (1.5 mL). The mixture was stirred at the same temperature for 
additional 3.5 h upon which 2-propanol was added to consume the excess Jones reagent. The 
solution was then evaporated in vacuo. The resulting residue was diluted with ethyl acetate, 
washed with water and brine, successively. The organic layer was dried over magnesium 
sulfate, filtered and evaporated in vacuo. The residue was purified by flash column 
chromatography on silica gel (ethyl acetate) to afford 6 (96 mg, 73% yield). 
1
H NMR (400 
MHz, CDCl3) δ 7.31 (dd, 1H, J = 7.2 Hz, 1.6 Hz), 7.31-7.23 (m, 2H), 7.02 (dd, 1H, J = 8.0 
Hz, 1.6 Hz), 5.97 (s, 1H), 5.58 (s, 1H), 3.88 (s, 3H), 2.85 (t, 2H, J = 7.6 Hz), 2.67 (t, 2H, J = 
7.6 Hz); 
13
C NMR (100 MHz , CDCl3) δ 182.0, 181.4, 177.7, 159.6, 159.1, 150.8, 132.2, 
131.2, 128.8, 127.3, 121.5, 108.8, 105.9, 56.9, 34.0, 25.0. 
 
Compound 8 
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 To a solution of 1,2,4-trimethoxybenzene 7 (1g, 5.95 mmol) in dichloromethane (20 
mL) at 0 
°
C was added bromine (0.34 mL, 6.54 mmol) in dichloromethane (5 mL). After 
stirring for 2.5 h at the same temperature, saturated aqueous sodium thiosulfate solution was 
added to quench the reaction. The resulting solution was diluted with dichloromethane, 
washed with water and brine, successively. The organic layer was dried over magnesium 
sulfate, filtered and evaporated in vacuo. The residue was purified by flash column 
chromatography on silica gel (hexanes : ethyl acetate = 3:1) to afford 8
14
 (1.39 g, 95% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.04 (s, 1H), 6.57 (s, 1H), 3.90 (s, 3H), 3.88 (s, 3H), 3.84 (s, 
3H). 
 
Compound 9 
 To a solution of 8 (1g, 4.05 mmol) in acetonitrile : water (1:2, 45 mL) was added 
ceric ammonium nitrate (6 g, 10.93 mmol). After 3 h at rt, the reaction mixture was diluted 
with ethyl acetate, washed with water and brine, successively. The organic layer was dried 
over magnesium sulfate, filtered and evaporated in vacuo. The residue was purified by flash 
column chromatography on silica gel (ethyl acetate) to afford 9
15
 (0.69 g, 79% yield). 
1
H 
NMR (400 MHz, CDCl3) δ 7.25 (s, 1H), 6.14 (s, 1H), 3.87 (s, 3H). 
 
Compound 11 
 To a suspension of lithium aluminum hydride (0.62 g, 16.20 mmol) in diethyl ether 
(15 mL) at 0 
O
C, was added 3,4-dihydrocoumarin 10 (1.71 mL, 13.50 mmol) in diethyl ether 
(15 mL). The reaction mixture was gently warmed to rt and then heated to reflux for 4 h, after 
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which, it was cooled to rt and stirred for 7.5 h at rt. 0.6 mL water, 0.6 mL of 15% aqueous 
sodium hydroxide solution and 1.8 mL water were then added, successively, to quench the 
reaction. The resulting solution was diluted with ethyl acetate, washed with water and brine, 
successively. The organic layer was dried over magnesium sulfate, filtered and evaporated in 
vacuo. The residue was purified by flash column chromatography on silica gel 
(dichloromethane : ethyl acetate = 4:1) to afford 11
16
 (1.42 g, 69% yield). 
1
H NMR (400 
MHz, CDCl3) δ 7.14-7.10 (m, 2H), 7.05 (s, 1H), 6.90-6.84 (m, 2H), 3.66 (t, 2H, J = 6.0 Hz), 
2.79 (t, 2H, J = 6.8 Hz), 2.46 (s, 1H), 1.93-1.86 (m, 2H). 
 
Compound 12 
 To a solution of 2-(3-hydroxypropyl)-phenol 11 (220 mg, 1.44 mmol) in N,N-
dimethylformamide (5 mL) was added potassium carbonate (200 mg, 1.44 mmol). After 30 
min at rt, 9 (300 mg, 1.38 mmol) in N,N -dimethylformamide (10 mL) was added to the 
reaction mixture. The mixture was stirred at rt for additional 3.5 h upon which it was 
quenched with 1N hydrochloric acid. The resulting solution was diluted with ethyl acetate, 
washed with water and brine, successively. The organic layer was dried over magnesium 
sulfate, filtered and evaporated in vacuo. The residue was purified by flash column 
chromatography on silica gel (hexanes : ethyl acetate = 1:1) to afford 12 (234 mg, 59% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.31 (dd, 1H, J = 6.8 Hz, 2.4 Hz), 7.28-7.21 (m, 2H), 7.00 
(dd, 1H, J = 7.2 Hz, 2.0 Hz), 5.95 (s, 1H), 5.58 (s, 1H), 3.85 (s, 3H), 3.58 (s, 2H), 2.58 (t, 2H, 
J = 7.2 Hz) 2.23 (s, 1H), 1.83-1.77 (m, 2H); 
13
C NMR (100 MHz , CDCl3) δ 181.9, 181.7, 
159.7, 158.9, 150.7, 133.8, 131.6, 128.1, 127.3, 121.1, 108.5, 105.7, 61.2, 56.9, 33.5, 25.8. 
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CHAPTER 3: DIRECT SYNTHESIS OF NATURAL PRODUCTS FROM 
HYPERICUM AND GARCINIA 
 
Introduction 
Natural products derived from plants are increasingly being investigated as leads for 
pharmaceutical development. Using bio-activity directed fractionation of plants reported to 
be useful as folk medicines, valuable bioactive compounds have been discovered. The 
recently found new plant derived pharmaceuticals include Taxotere, Camptosar and 
teniposide.
1
 As part of a multidisciplinary endeavor to identify new antiviral agents from 
Echinacea and Hypericum,
2
 we required a flexible synthetic route to aurones and 
benzophenones. 
Aurones are less common than flavones and have been reported to arise from 
chalcones by a biosynthetic pathway catalyzed by aureusidin synthase, a polyphenol oxidase 
homolog responsible for flower coloration.
3,4
 Certain aurones show in vitro activity against 
Cryptosporidium parvum and Plasmodium falciparum.
5
 Some naturally occurring 4,6-
dioxygenated aurones show high-affinity binding to the cytosolic domain of P-glycoprotein 
and inhibit respiratory functions of mitochondria of Leishmania parasites (Figure 1).
6
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O
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Figure 1 
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Aurones have been synthesized, chiefly, by three methods. The first one involves 
cyclization of alkynyl ketones (Scheme 1).
7
 The second route to aurones entails condensation 
of aromatic aldehydes with substituted benzofuran-3-ones, which are used as the key building 
blocks (Scheme 2).
8
 The third method prepares an aurone by reaction of o-iodophenol with 
phenylacetylene in presence of potassium acetate and catalytic Pd(PPh3)4 under carbon 
monoxide atmosphere (Scheme 3).
9
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Our group has successfully developed a novel one-step approach to aurones. A Wittig 
reaction of 4-nitrobenzyltriphenylphosphorane with 4,6-dimethoxybenzofuran-2,3-dione 
affords an aurone in a single step. The nitro group is reduced by tin and hydrochloric acid to 
provide an amino aurone (Scheme 4). 
O
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MeO
O2N
PPh3
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t-BuOK
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Scheme 4 
Recently, our group has also developed a novel way to make aurones using 1,3-
benzodioxin-4-one 3 as the key starting unit. Reaction of acetonide 3 with phenylacetylide 
followed by cyclization of the intermediate using potassium carbonate furnished aurone 1 
(Scheme 5).
10 
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Benzophenones, especially the prenylated ones, derived from Garcinia species 
(Figure 2) often show a broad range of pharmacological and biological activities like 
antioxidant, anti-inflammatory, antimicrobial, cytotoxic and inhibitory effects on monoamine 
oxidase and xanthine oxidase.
11 
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Figure 2 
The key structural feature of these benzophenones is the multiple oxygen atoms 
attached to the phenyl rings, of which a few functional groups are methylated. The 
disposition of these groups on both aromatic rings makes them interesting molecules to 
synthesize using a common methodology. Herein, we describe syntheses of a naturally 
occurring aurone 2 (Scheme 9) along with two other plant derived benzophenones 4 and 5 
(Schemes 11 and 14) using 1,3-benzodioxin-4-ones and substituted phenyl acetylene or aryl 
bromide species. 
 
Results and Discussion 
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As shown in the retrosynthetic analysis, we envisioned that aurone 2 could be 
assembled via a reaction of 1,3-benzodioxin-4-one 3 with 3,4-dimethoxyphenyl acetylene (8) 
(Scheme 6).  
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Scheme 6 
The 1,3-benzodioxin-4-one 3 could in turn be synthesized from the commercially 
available 2,4,6-trihydroxybenzoic acid (9) (Scheme 7). The acetonide 10 was synthesized 
from 9 using thionyl chloride, acetone and catalytic N,N-dimethylaminopyridine in 1,2-
dimethoxyethane according to the procedure reported by Kamisuki and coworkers.
12 
Diol 10 
was methylated using methyl iodide and potassium carbonate in acetone to furnish 1,3-
benzodioxin-4-one 3 in 95% isolated yield (Scheme 7).
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Scheme 7 
The 3,4-dimethoxyphenylacetylene (8) was made from commercially available 3,4-
dimethoxybenzaldehyde (11) using the Corey-Fuchs sequence in two steps (Scheme 8).
13
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Scheme 8 
Treatment of acetonide 3 with the lithium anion of 8 generated the acetylenic ketone 
13, which readily cyclized to aurone 2 upon reaction with potassium carbonate in acetone at 
56 
°
C under sealed tube conditions (Scheme 9). The exclusive 5-exo reaction pathway has 
precedent in the work of Garcia.
7 
The identity of synthesized aurone 2 was confirmed by 
comparison of the obtained 
1
H NMR, LRMS and HRMS data with the published ones.
14
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In the second part of the project, we employed the above methodology to synthesize 
natural products 4 and 5 with benzophenone skeleton and thus demonstrated versatility of the 
strategy. Guaiacol (14) was selectively brominated at the position para to the hydroxyl group 
using tetrabutylammoniumtribromide (TBATB) in dichloromethane to give 15 in 76% 
yield.
15
 Benzyl protection of the hydroxyl group in 15 afforded 16 in 94% isolated yield 
(Scheme 10).
16 
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The bromo compound 16 was lithiated and allowed to react with 3 to give 
benzophenone 17 in 70% yield. Removal of the benzyl protecting group in 17 using H2 and 
10% palladium on carbon afforded the natural product 4 in 73% yield (Scheme 11). The 
identity of synthesized benzophenone 4 was confirmed by comparison of the obtained 
1
H 
NMR, 
13
C NMR, LRMS and HRMS data with the published ones.
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After successfully employing the methodology to synthesize 4, we directed our 
attention to the natural product 5. The first component, 20, was prepared in two steps starting 
from catechol (18). Catechol was mono-brominated in quantitative yield using N-
bromosuccinimide and tetrafluoroboric acid (54 weight percent solution in diethyl ether) in 
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acetonitrile.
18,19
 Benzyl protection of diol 19 using benzyl bromide and potassium carbonate 
provided 20 in 71% yield (Scheme 12).
19 
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Scheme 12 
Benzylation of diol 10 using benzyl bromide and potassium carbonate afforded 1,3-
benzodioxin-4-one 21
20
 in 85% yield. Benzenesulfonylation of 10 using benzenesulfonyl 
chloride and triethylamine provided 22 in 96% yield (Scheme 13). 
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Scheme 13 
Having the two components for the reaction ready, 20 was lithiated and allowed to 
react with acetonide 21 to provide benzophenone 23 in 36% yield. Methylation of 23 using 
dimethyl sulfate and potassium carbonate in acetone followed by removal of the benzyl 
protecting groups in 24 afforded the target molecule 5 in quantitative yield over two steps 
(Scheme 14). The identity of synthesized benzophenone 5 was confirmed by comparison of 
the obtained 
1
H NMR, 
13
C NMR, LRMS and HRMS data with the published ones.
21
 
47 
 
1. n-BuLi
2.
O
O
Me
Me
OBn O
BnO
36%
OBn
OBn
Br
O
OBn
OBn
OBn
BnO OH
O
OBn
OBn
OBn
BnO OMe
O
OH
OH
OH
HO OMe
K2CO3, Me2SO4
acetone, reflux
MeOH:EtOAc (1:1), rt
100% over two steps
H2, 10% Pd/C
20 (21)
24
23
5  
Scheme 14 
In a parallel effort, we tried to apply the above developed strategy to synthesize the 
natural product 6. With that in mind, the lithium anion of 16 was made to react with 1,3-
benzodioxin-4-one 22 to furnish benzophenone 25 in 63% isolated yield. Unfortunately, our 
attempts to make the precursor 26 for the Claisen rearrangement were not fruitful (Scheme 
15). 
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Adduct 25 was O-allylated using allyl bromide and potassium carbonate. However, 
the attempted Claisen rearrangement failed, presumably due to decomposition of the 
synthesized intermediate at 185 
°
C under sealed tube conditions (Scheme 16). To avoid 
subjecting the compounds to the harsh thermal conditions involved in Claisen rearrangement, 
we planned to introduce the prenyl group by a different approach. 
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Compound 16 was lithiated and allowed to react with acetonide 21 to afford 
benzophenone 28, which was methylated using dimethyl sulfate and potassium carbonate to 
provide the intermediate 29. Iodination of 29 was not regioselective and led to multiple 
iodinated products. Removal of the benzyl protecting groups in 29 using H2 and 10% 
palladium on carbon provided 30. Unfortunately, the attempted regioselective prenylation led 
to decomposition of the starting material 30 (Scheme 17). 
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Scheme 17 
In an altered approach to get the target compound 6, acetonide 21 was regioselectively 
iodinated using iodine monochloride to provide the iodo compound 32 in 85 % isolated 
yield.
22 
Stille coupling of 32 with allyltributylstannane afforded the allylated product 33 in 
78% yield (Scheme 18).
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Compound 16 was made to react with the allylated compound 33 to provide 
benzophenone 34, which was methylated using methyl iodide and potassium carbonate in 
acetone to afford 35 in 39% yield over two steps (Scheme 19).  
OBn
OMe
Br
1. n-BuLi
2.
O
O
Me
Me
OBn O
BnO
OH
OBn O
BnO OBn
OMe
acetone, reflux
39% (over two steps)
OMe
OBn O
BnO OBn
OMe
K2CO3, MeI
(33)
16 34
35  
Scheme 19 
At this stage, we were only two steps away from the target molecule 6. We tried 
converting the allyl group of 35 into a prenyl group using cross metathesis.
24
 To our dismay, 
both attempts to react 35 with 2-methyl-2-butene, under solvent as well as solvent-free (neat) 
conditions, returned the starting material (Scheme 20). 
HCOONH4,Pd/C
ref. 27
OMe
OBn O
BnO
OBn
OMe
CDCl3, rt
10 mol%
Grubbs' 2nd generation catalyst
rt
OMe
OBn O
BnO
OBn
OMe
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In a different route to target molecule 6, we planned to make the prenyl compound 38 
first. Prenylation of the iodo compound 32, however, was not straight forward. Although the 
allylation of 32 under the Stille coupling conditions went smoothly (Scheme 18), the 
coupling with prenyltributylstannane
25,26
 (37) was far more challenging (Table 1).  
I
O
O
Me
Me
OBn O
BnO
SnBu3
O
O
Me
Me
OBn O
BnO
See Table 1
(37)
32 38
Prenylation condition Outcome
1. cat. Pd2dba3, cat. P(2-furyl)3, 
CsF, NMP, reflux
2. cat. Pd2dba3, cat. P(2-furyl)3, 
CsF, NMP, 100 °C, sealed tube
3. cat. Pd2dba3, cat. 
Pd(PPh3)2Cl2, cat. P(2-furyl)3, 
CsF, DMF, 100 °C
4. cat. Pd(PPh3)2Cl2,
cat. P(2-furyl)3, CsF, DMF,100 °C
5. cat. Pd(PPh3)2Cl2,
cat. P(2-furyl)3, CsF, DMF, 
microwave, 150 °C
deiodinated compd + SM 
recovered
SM recovered
Trace amount of pdt
37% yield + SM recovered
compound decomposed
 
Table 1 
We tried a variety of different conditions by modifying the catalyst from palladium 
(0) to palladium (II), changing the solvent from N-Methylpyrrolidone to N,N-
dimethylformamide and also varying the mode of heating from reflux conditions to heating in 
a sealed tube to making use of the microwave. Either starting material was recovered (entries 
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1 and 2, Table 1) or the harsh thermal conditions led to decomposition (entry 5). The entry 4 
was the sole acceptable one, which gave the desired product 38 in 37% yield. The pathway 
we intend to follow from 38 to the target compound 6 has been outlined in Scheme 21. 
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Scheme 21 
 
Conclusion 
 In summary, we have successfully developed a methodology to synthesize aurones 
and benzophenones, both of which have been reported to exhibit potent biological activity. 
Using 1,3-benzodioxin-4-ones as our key unit gives us a useful intermediate for the synthesis 
of other structurally related natural products in a direct approach. 
 
Experimental Section 
 Unless otherwise noted, materials were obtained from commercial suppliers and used 
without purification. All experiments were performed under argon atmosphere unless 
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otherwise noted. Nuclear magnetic resonance experiments were performed with either a 
Varian 300 MHz or a Varian 400 MHz instrument. All chemical shifts are reported relative to 
CDCl3 (7.27 ppm for 
1
H NMR and 77.23 ppm for 
13
C NMR) unless otherwise noted. 
Coupling constants (J) are reported in Hz with abbreviations: s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet. High resolution mass spectra were recorded on a Kratos 
model MS-50 spectrometer and low resolution mass spectra were performed with a Finnegan 
TSQ700 mass spectrometer. Standard grade silica gel (60 A, 32-63 µm) was used for flash 
column chromatography. 
 
Compound 2 
To a solution of 13 (25 mg, 0.073 mmol) in acetone (5 mL), taken in a sealable tube, 
was added potassium carbonate (31 mg, 0.22 mmol) at rt. The reaction mixture was heated in 
the sealed tube for 6 h at 56 
°
C after which it was cooled to rt, passed through a pad of Celite 
and then evaporated in vacuo. The residue was purified by flash column chromatography on 
silica gel (hexanes : ethyl acetate = 1:4) to afford aurone 2
13
 (20 mg, 80% yield). 
1
H NMR 
(400 MHz, CDCl3) δ 7.46-7.44 (m, 2H), 6.93 (d, 1H, J = 8.4 Hz), 6.75 (s, 1H), 6.36 (d, 1H, J 
= 1.6 Hz), 6.14 (d, 1H, J = 1.6 Hz), 3.97 (s, 3H), 3.96 (s, 3H), 3.94 (s, 3H), 3.92 (s, 3H); 
LRMS (EI): m/z 342 (M
+
, 100%), 311, 180; HRMS (EI) calcd for C19H18O6: 342.1103, 
found: 342.1108. 
 
Compound 3 
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To a solution of 10 (0.36 g, 1.7 mmol) in acetone (20 mL) was added potassium 
carbonate at rt. After cooling to 0 
°
C, methyl iodide (1.1 mL, 17 mmol) was added and the 
reaction mixture was gradually warmed to rt and stirred overnight. The reaction was 
quenched with 0.5 M acetic acid. The resulting solution was diluted with ethyl acetate, 
washed with water and brine, successively. The organic layer was dried over magnesium 
sulfate, filtered and evaporated in vacuo. The residue was purified by flash column 
chromatography on silica gel (hexanes : ethyl acetate = 4:1) to afford the dimethoxy 
compound 3
9
 (0.38 g, 95% yield) as a white solid: mp 126-128 
°
C; 
1
H NMR (400 MHz, 
CDCl3) δ 6.15 (d, 1H, J = 2.0 Hz), 6.08 (d, 1H, J = 2.0 Hz), 3.93 (s 3H), 3.85 (s, 3H), 1.71 (s, 
6H); 
13
C NMR (100 MHz, CDCl3) δ 166.6, 163.0, 160.0, 158.5, 105.2, 96.8, 94.0, 93.6, 56.5, 
55.9, 25.8; LRMS (EI): m/z 238 (M
+
), 180 (100%), 152, 137; HRMS (EI) calcd for C12H14O5: 
238.0841, found: 238.0845. 
 
Compound 4 
To a solution of 17 (50 mg, 0.13 mmol) in methanol : ethyl acetate (10:7, 17 mL) was 
added 10 % palladium on carbon (30 mg). After 18 h at rt under H2 atmosphere (H2 balloon), 
the reaction mixture was passed through a pad of Celite and then evaporated in vacuo. The 
residue was purified by preparative TLC on silica gel (hexanes : ethyl acetate = 2:1) to afford 
the natural product 4
16
 (28 mg, 73% yield). 
1
H NMR (400 MHz, CDCl3) δ 11.64 (s, 1H), 7.25 
(d, 1H, J = 2.0 Hz), 7.16 (dd, 1H, J = 8.4 Hz, 2.0 Hz), 6.89 (d, 1H, J = 8.4 Hz), 6.18 (d, 1H, J 
= 2.4 Hz), 6.04 (s, 1H), 5.97 (d, 1H, J = 2.0 Hz), 3.93 (s, 3H), 3.86 (s, 3H), 3.54 (s, 3H); 
13
C 
NMR (100 MHz, CDCl3) δ 197.4, 166.0, 165.1, 161.6, 149.2, 146.1, 133.5, 124.3, 113.4, 
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111.0, 106.0, 93.9, 91.6, 56.3, 55.8, 55.4; LRMS (EI): m/z 304 (M
+
), 303 (100%), 287, 181; 
HRMS (EI) calcd for C16H16O6: 304.0947, found: 304.0952. 
 
Compound 5 
To a solution of 24 (153 mg, 0.24 mmol) in methanol : ethyl acetate (1:1, 30 mL) was 
added 10 % palladium on carbon (100 mg). After 6 h at rt under H2 atmosphere (H2 balloon), 
the reaction mixture was passed through a pad of Celite and then evaporated in vacuo. The 
residue was purified by flash column chromatography on silica gel (ethyl acetate) to afford 
the natural product 5
20
 (66 mg, 100% yield over two steps). 
1
H NMR (400 MHz, CD3OD) δ 
7.17 (d, 1H, J = 2.0 Hz), 7.09 (dd, 1H, J = 8.4 Hz, 2.0 Hz), 6.73 (d, 1H, J = 8.4 Hz), 5.96 (d, 
1H, J = 5.6 Hz), 3.55 (s, 3H); 
13
C NMR (75 MHz, CD3OD) δ 198.3, 163.2, 161.7, 160.8, 
151.7, 146.0, 133.2, 124.3, 117.4, 115.6, 108.7, 96.7, 92.2, 56.0; LRMS (EI): m/z 276 (M
+
, 
100%), 260, 167; HRMS (EI) calcd for C14H12O6: 276.0634, found: 276.0638. 
 
Compound 8 
To a solution of 12 (1.75 g, 5.43 mmol) in tetrahydrofuran (50 mL) at -78 
°
C was 
added n-BuLi (2.5 M solution in hexanes, 5.44 mL, 13.59 mmol). The reaction mixture was 
gradually warmed to rt and stirred overnight upon which it was quenched with saturated 
aqueous ammonium chloride solution. The resulting solution was diluted with ethyl acetate, 
washed with water and brine, successively. The organic layer was dried over magnesium 
sulfate, filtered and evaporated in vacuo. The residue was purified by flash column 
chromatography on silica gel (hexanes : ethyl acetate = 6:1) to afford 8
12
 as a pale yellow 
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solid: mp 66-68 
°
C; 
1
H NMR (300 MHz, CDCl3) δ 7.12 (dd, 1H, J = 8.1 Hz, 1.8 Hz), 7.0 (d, 
1H, J = 1.8 Hz), 6.81 (d, 1H, J = 8.1 Hz), 3.90 (s, 3H), 3.89 (s, 3H), 3.01 (s, 1H); 
13
C NMR 
(100 MHz, CDCl3) δ 149.9, 148.7, 125.6, 114.8, 114.3, 111.0, 83.9, 75.9, 56.0. 
 
Compound 10
11
: 
1
H NMR (300 MHz, acetone-d6) δ 10.45 (s, 1H), 9.74 (br s, 1H), 6.07 (d, 
1H, J = 2.4 Hz), 6.00 (d, 1H, J = 2.4 Hz), 1.71 (s, 6H); 
13
C NMR (100 MHz, acetone-d6) δ 
167.2, 165.8, 164.1, 158.2, 107.7, 98.0, 96.3, 93.1, 25.7. 
 
Compound 12 
To a solution of 3,4-dimethoxybenzaldehyde 11 (1 g, 6.02 mmol) in dichloromethane 
(50 mL) was added triphenylphosphine (3.16 g, 12.05 mmol) at rt. After cooling to 0 
°
C, 
carbon tetrabromide (2.2 g, 6.63 mmol) in dichloromethane (10 mL) was added dropwise. 
The reaction mixture was stirred for 2 h at 0 
°
C and then 2 h at rt before being quenched by 
adding water. The resulting solution was diluted with dichloromethane, washed with water 
and brine, successively. The organic layer was dried over magnesium sulfate, filtered and 
evaporated in vacuo. The residue was purified by flash column chromatography on silica gel 
(hexanes : ethyl acetate = 9:1) to afford the dibromo compound 12
12
 (1.77 g, 91% yield). 
1
H 
NMR (400 MHz, CDCl3) δ 7.42 (s, 1H), 7.2 (d, 1H, J = 1.6 Hz), 7.11 (dd, 1H, J = 8.4 Hz, 2.0 
Hz), 6.87 (d, 1H, J = 8.4 Hz), 3.91 (s, 3H), 3.90 (s, 3H). 
 
Compound 13 
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To a solution of 3,4-dimethoxyphenylacetylene (8) (200 mg, 1.24 mmol) in 
tetrahydrofuran (10 mL) at 0 
°
C was added n-BuLi (2.5 M solution in hexanes, 0.5 mL, 1.24 
mmol). After 1 h at 0 
°
C, the solution was cooled further to – 78 
°
C and 3 (150 mg, 0.62 
mmol) in tetrahydrofuran (5 mL) was added dropwise. The reaction mixture was gradually 
warmed to rt and stirred overnight upon which it was quenched with 4.3 N acetic acid. The 
resulting solution was diluted with ethyl acetate, washed with water and brine, successively. 
The organic layer was dried over magnesium sulfate, filtered and evaporated in vacuo. The 
residue was purified twice by flash column chromatography on silica gel (hexanes : ethyl 
acetate = 6:1 and dichloromethane : ethyl acetate, 19:1) to afford the acetylenic ketone 13 (66 
mg, 31% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.28-7.27 (m, 1H), 7.14 (s, 1H), 6.89 (d, 1H, 
J = 8.4 Hz), 6.09 (d, 1H, J = 2.4 Hz), 5.96 (d, 1H, J = 2.0 Hz), 3.95 (s, 3H), 3.94 (s, 3H), 3.92 
(s, 3H), 3.86 (s, 3H). 
 
Compound 15 
To a solution of guaiacol (14) (0.65 mL, 8.06 mmol) in CH2Cl2 (80 mL) was added 
tetrabutylammonium tribromide (3.88 g, 8.06 mmol) at rt. After stirring for 16 h at rt, the 
reaction mixture was quenched with saturated aqueous sodium thiosulfate solution. The 
resulting solution was diluted with dichloromethane, washed with water and brine, 
successively. The organic layer was dried over magnesium sulfate, filtered and evaporated in 
vacuo. The residue was purified by flash column chromatography on silica gel (hexanes : 
ethyl acetate = 6:1) to afford the bromo compound 15
14
 (1.23 g, 76% yield). 
1
H NMR (300 
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MHz, CDCl3) δ 7.01 (d, 1H, J = 2.4 Hz), 6.98 (t, 1H, J = 2.4 Hz), 6.81 (d, 1H, J = 8.1 Hz), 
5.54 (s, 1H), 3.90 (s, 3H). 
 
Compound 16 
To a solution of 15 (5.5 g, 27.0 mmol) in acetone (150 mL) were added cesium 
carbonate (9.24 g, 28.4 mmol) and benzylbromide (3.06 mL, 25.7 mmol) at rt. After boiling 
for 4.5 h, the reaction mixture was cooled to rt, passed through a pad of Celite and evaporated 
in vacuo. The residue was purified by flash column chromatography on silica gel (hexanes : 
ethyl acetate = 19:1) to afford the benzyloxy compound 16
15
 (7.05 g, 94% yield) as a white 
solid: mp 59-61 
°
C (lit
15
 61-61.2 
°
C) 
1
H NMR (400 MHz, CDCl3) δ 7.44-7.32 (m, 5H), 7.01 
(d, 1H, J = 2.0 Hz), 6.97 (dd, 1H, J = 8.8 Hz, 2.4 Hz), 6.75 (d, 1H, J = 8.4 Hz), 5.14 (s, 2H), 
3.88 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 150.6, 147.5, 136.8, 128.8, 128.1, 127.4, 123.5, 
115.4, 115.3, 113.5, 71.3, 56.3. 
 
Compound 17 
To a solution of 16 (295 mg, 1.01 mmol) in tetrahydrofuran (10 mL) at -78 
°
C was 
added n-BuLi (2.5 M solution in hexanes, 0.38 mL, 0.94 mmol). After stirring for 1.5 h at -78 
°
C was added 3 (80 mg, 0.34 mmol) in tetrahydrofuran (5 mL). The reaction mixture was 
warmed to -50 
°
C over 45 min and then quenched with glacial acetic acid in tetrahydrofuran. 
The resulting solution was diluted with ethyl acetate, washed with water and brine, 
successively. The organic layer was dried over magnesium sulfate, filtered and evaporated in 
vacuo. The residue was purified by flash column chromatography on silica gel (hexanes : 
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ethyl acetate = 9:1 to 4:1) to afford benzophenone 17 (93 mg, 70% yield). 
1
H NMR (400 
MHz, CDCl3) δ 11.75 (s, 1H), 7.46-7.30 (m, 5H), 7.23 (d, 1H, J = 1.6 Hz), 7.15 (dd, 1H, J = 
8.4 Hz, 1.6 Hz), 6.87 (d, 1H, J = 8.4 Hz), 6. 18 (d, 1H, J = 2.4 Hz), 5.96 (d, 1H, J = 2.4 Hz), 
5.23 (s, 2H), 3.91 (s, 3H), 3.85 (s, 3H), 3.50 (s, 3H). 
 
Compound 19 
To a solution of catechol (18) (1g, 9.08 mmol) in acetonitrile (10 mL) at -45 
°
C, were 
added tetrafluoroboric acid in diethyl ether (54 wt% solution in diethyl ether, 2.25 mL, 16.35 
mmol) and N-bromosuccinimide (1.70 g, 9.54 mmol) successively. The reaction mixture was 
allowed to gradually warm to rt and stirred for 12 h, after which it was poured into water and 
extracted with diethyl ether. The ether layer was washed with 4% aqueous sodium bisulfite 
solution and brine, successively. The organic layer was then dried over magnesium sulfate, 
filtered and evaporated in vacuo. The residue was purified by flash column chromatography 
on silica gel (hexanes : ethyl acetate = 3:2) to afford the bromo compound 19
18
 (1.72 g, 100% 
yield). 
1
H NMR (400 MHz, CDCl3) δ 7.03 (d, 1H, J = 2.4 Hz), 6.93 (dd, 1H, J = 8.4 Hz, 2.0 
Hz), 6.76 (d, 1H, J = 8.4 Hz), 5.79 (br s, 1H), 5.62 (br s, 1H).  
 
Compound 20 
To a solution of 19 (1.70 g, 8.99 mmol) in acetone (70 mL) were added potassium 
carbonate (4.96 g, 35.96 mmol) and benzyl bromide (4.06 mL, 34.16 mmol). After boiling for 
7 h, the reaction mixture was cooled to rt, passed through a pad of Celite and evaporated in 
vacuo. The residue was purified by flash column chromatography on silica gel (hexanes : 
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ethyl acetate = 19:1) to afford compound 20
18
 (2.34 g, 71% yield) as a white solid: mp 65-67 
°
C (lit
18
 64-66 
°
C); 
1
H NMR (400 MHz, CDCl3) δ 7.47-7.33 (m, 10H), 7.09 (d, 1H, J = 2.4 
Hz), 7.01 (dd, 1H, J = 8.4 Hz, 2.4 Hz), 6.81 (d, 1H, J = 8.8 Hz), 5.14 (s, 4H); 
13
C NMR (100 
MHz, CDCl3) δ 150.0, 148.3, 137.0, 136.7, 128.8, 128.7, 128.2, 128.1, 127.5, 127.4, 124.3, 
118.2, 116.6, 113.6, 71.6, 71.5. 
 
Compound 21 
To a solution of diol 10 (300 mg, 1.43 mmol) in acetone (20 mL) at 0 
°
C, were added 
potassium carbonate (986 mg, 7.14 mmol) and benzyl bromide (0.68 mL, 5.71 mmol). The 
reaction mixture was gradually warmed to rt and then heated to reflux for 18 h after which 
the reaction mixture was cooled to rt, passed through a pad of Celite and evaporated in vacuo. 
The residue was purified by flash column chromatography on silica gel (hexanes : ethyl 
acetate = 3:1) to afford acetonide 21
19
 (476 mg, 85% yield) as a pale yellow solid: mp 117-
119 
°
C (lit
19
 119-120 
°
C); 
1
H NMR (400 MHz, CDCl3) δ 7.55-7.53 (m, 2H), 7.42-7.29 (m, 
8H), 6.27 (d, 1H, J = 2.4 Hz), 6.16 (d, 1H, J = 2.4 Hz), 5.20 (s, 2H), 5.04 (s, 2H), 1.72 (s, 
6H); 
13
C NMR (100 MHz , CDCl3) δ 165.4, 161.8, 159.5, 158.1, 136.3, 135.7, 128.9, 128.8, 
128.6, 128.0, 127.8, 126.8, 105.2, 97.5, 96.1, 94.8, 70.7, 70.6, 25.8. 
 
Compound 22 
To a solution of 10 (0.52 g, 2.48 mmol) in tetrahydrofuran (20 mL) was added 
triethylamine (1.73 mL, 12.4 mmol). The reaction solution was cooled to 0 
°
C, 
benzenesulfonyl chloride (1.43 mL, 11.2 mmol) was added and the reaction mixture was 
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gradually warmed to rt overnight. The reaction was quenched with 0.5 M acetic acid and the 
resulting solution was diluted with ethyl acetate, washed with water and brine, successively. 
The organic layer was dried over magnesium sulfate, filtered and evaporated in vacuo. The 
residue was purified by flash column chromatography on silica gel (hexanes : ethyl acetate = 
4:1) to afford compound 22 (1.16 g, 96% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.87-8.00 (m, 
4H), 7.54-7.78 (m, 6H), 6.77 (s, 1H), 6.89 (s, 1H), 1.62 (s, 6H). 
 
Compound 23 
To a solution of 20 (850 mg, 2.31 mmol) in tetrahydrofuran (20 mL) at -78 
°
C was 
added n-BuLi (2.5 M solution in hexanes, 0.86 mL, 2.15 mmol). After stirring for 1.5 h at – 
78 
°
C, 21 (300 mg, 0.77 mmol) in tetrahydrofuran (10 mL) was added and the reaction 
mixture was warmed to rt over 4 h. After stirring for a further 2.5 h at rt, the reaction was 
quenched with saturated aqueous ammonium chloride solution. The resulting solution was 
diluted with ethyl acetate, washed with water and brine, successively. The organic layer was 
dried over magnesium sulfate, filtered and evaporated in vacuo. The residue was purified by 
flash column chromatography on silica gel (hexanes : ethyl acetate = 9:1) to afford 
benzophenone 23 (170 mg, 36% yield). 
1
H NMR (300 MHz, CDCl3) δ 7.47-7.12 (m, 20H), 
6.81 (d, 1H, J = 8.4 Hz), 6.71 (d, 2H, J = 6.3 Hz), 6.28 (d, 1H, J = 2.1 Hz), 6.08 (d, 1H, J = 
2.1 Hz), 5.13 (s, 2H), 5.11 (s, 2H), 5.08 (s, 2H), 4.68 (s, 2H). 
 
Compound 24 
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To a solution of 23 (150 mg, 0.24 mmol) in acetone (10 mL) were added potassium 
carbonate (133 mg, 0.96 mmol) and dimethyl sulfate (0.08 mL, 0.84 mmol). After heating to 
reflux for 9 h, the reaction mixture was cooled to rt, passed through a pad of Celite and 
evaporated in vacuo. The residue was purified by flash column chromatography on silica gel 
(hexanes : ethyl acetate = 3:1) to afford compound 24. 
1
H NMR (400 MHz, CDCl3) δ 7.62-
7.16 (m, 20H), 7.08-7.02 (m, 2H), 6.88 (d, 1H, J = 8.4 Hz), 6.24 (s, 2H), 5.23 (s, 2H), 5.16 (s, 
2H), 5.07 (s, 2H), 4.92 (s, 2H), 3.66 (s, 3H); LRMS (EI): m/z 636 (M
+
), 545, 372, 347, 181 
(100%); HRMS (EI) calcd for C42H36O6: 636.2512, found: 636.2522. 
 
Compound 25 
To a solution of 16 (610 mg, 2.08 mmol) in tetrahydrofuran (10 mL) at -78 
°
C was 
added n-BuLi (2.5 M solution in hexanes, 0.79 mL, 1.98 mmol). After stirring for 2 h at – 78 
°
C, 22 (255 mg, 0.52 mmol) in tetrahydrofuran (10 mL) was added and the reaction mixture 
was warmed to 5 
°
C over 3 h. The reaction was quenched with saturated aqueous ammonium 
chloride solution. The resulting solution was diluted with ethyl acetate, washed with water 
and brine, successively. The organic layer was dried over magnesium sulfate, filtered and 
evaporated in vacuo. The residue was purified by flash column chromatography on silica gel 
(hexanes : ethyl acetate = 2:1) to afford benzophenone 25 (213 mg, 63% yield). 
1
H NMR 
(300 MHz, CDCl3) δ 9.97 (s, 1H), 7.34-7.95 (m, 15H), 7.20 (d, 1H, J = 1.8 Hz), 7.08 (dd, 1H, 
J = 8.4 Hz, 2.1 Hz), 6.80 (d, 1H, J = 8.4 Hz), 6.68 (d, 1H, J = 2.4 Hz), 6.52 (d, 1H, J = 2.1 
Hz), 5.21 (s, 2H), 3.91 (s, 3H). 
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Compound 30 
To a solution of 16 (450 mg, 1.54 mmol) in tetrahydrofuran (10 mL) at -78 
°
C was 
added n-BuLi (2.5 M solution in hexanes, 0.58 mL, 1.46 mmol). After 1.5 h at -78 
°
C, 21 
(150 mg, 0.39 mmol) in tetrahydrofuran (10 mL) was added and the reaction mixture was 
warmed to -45 
°
C over 45 min. The reaction was quenched with glacial acetic acid in 
tetrahydrofuran and the resulting solution was diluted with ethyl acetate, washed with water 
and brine, successively. The organic layer was dried over magnesium sulfate, filtered and 
evaporated in vacuo to give crude benzophenone 28. 1H NMR (400 MHz, CDCl3) δ  7.13-
7.48 (m, 15H), 6.72-6.79 (m, 3H), 6.29 (d, 1H, J = 2.0 Hz), 6.14 (d, 1H, J = 2.0 Hz), 5.12 (s, 
2H), 5.11 (s, 2H), 4.81 (s, 2H), 3.87 (s, 3H). The crude compound 28 was used directly for 
the next step without further purification. 
To the above crude compound 28 taken up in acetone (10 mL) were added potassium 
carbonate (100 mg) and dimethyl sulfate (0.05 mL) and the reaction mixture was heated to 
reflux for 3 h. The reaction solution was cooled to rt, passed through a pad of Celite and 
evaporated in vacuo to give the crude compound 29. 1H NMR (400 MHz, CDCl3) δ 7.17-
7.64 (m, 15H), 7.03-7.08 (m, 2H), 6.81 (d, 1H, J = 8.4 Hz), 6.25 (s, 2H), 5.22 (s, 2H), 5.05 (s, 
2H), 4.96 (s, 2H), 3.94 (s, 3H), 3.69 (s, 3H). The crude compound 29 was used directly for 
the next step without further purification. 
To a solution of the above crude compound 29 in methanol (10 mL) was added 10 % 
palladium on carbon (50 mg). After stirring for 16 h at rt under H2 atmosphere (H2 balloon), 
the reaction mixture was passed through a pad of Celite and then evaporated in vacuo. The 
residue was purified by flash column chromatography on silica gel (ethyl acetate) to afford 
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30. 
1
H NMR (400 MHz, CDCl3) δ  7.24 (d, 1H, J = 2.0 Hz), 7.14 (dd, 1H, J = 8.4 Hz, 2.0 
Hz), 6.87 (d, 1H, J = 8.0 Hz), 6.09 (d, 1H, J = 2.0 Hz), 5.95 (d, 1H, J = 2.0 Hz), 3.92 (s, 3H), 
3.52 (s, 3H).  
 
Compound 32 
To a solution of 21 (100 mg, 0.26 mmol) in dimethyl sulfoxide : glacial acetic acid 
(1:1, 10 mL) at 0 
°
C was added iodine monochloride (1 M solution in dichloromethane, 0.46 
mL, 0.46 mmol) under dark (flask covered with aluminum foil). The reaction mixture was 
gradually warmed to rt and stirred overnight. The reaction was quenched with saturated 
aqueous sodium thiosulfate solution. The resulting solution was diluted with ethyl acetate, 
washed with saturated aqueous sodium bicarbonate solution and brine, successively. The 
organic layer was dried over magnesium sulfate, filtered and evaporated in vacuo. The 
residue was purified by flash column chromatography on silica gel (hexanes : ethyl acetate = 
4:1) to afford the iodo compound 32 (123 mg, 85% yield) as a white solid: mp 157-159 
°
C; 
1
H NMR (400 MHz, CDCl3) δ 7.46-7.51 (m, 2H), 7.28-7.46 (m, 8H), 6.25 (s, 1H), 5.21 (s, 
2H), 5.13 (s, 2H), 1.75 (s, 6H); 
13
C NMR (100 MHz, CDCl3) δ 163.6, 162.5, 158.2, 157.6, 
136.0, 135.5, 129.0, 128.9, 128.5, 128.2, 127.1, 126.9, 105.9, 98.5, 93.9, 71.3, 71.2, 66.4, 
26.0; LRMS (EI): m/z 516 (M
+
), 458 (100%), 390, 366, 332; HRMS (EI) calcd for 
C24H21IO5: 516.0434, found: 516.0445. 
 
Compound 33 
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To a solution of the iodo compound 32 (360 mg, 0.64 mmol) in N,N-
dimethyformamide (10 mL) were added allyltributylstannane (0.40 mL, 1.29 mmol) and 
dichlorobis(triphenylphosphine)-palladium(II) (45 mg, 0.064 mmol) and the reaction mixture 
was heated to 100 
°
C for 5 h. The reaction solution was cooled to rt, diluted with ethyl 
acetate, washed with aqueous ammonium hydroxide solution (29% solution in water) and 
brine, successively. The organic layer was dried over magnesium sulfate, filtered and 
evaporated in vacuo. The residue was purified by flash column chromatography on silica gel 
(hexanes : ethyl acetate = 9:1) to afford the allyl compound 33 (238 mg, 78% yield).
 1
H NMR 
(400 MHz, CDCl3) δ  7.50-7.54 (m, 2H), 7.26-7.44 (m, 8H), 6.25 (s, 1H), 5.81-5.93 (m, 1H), 
5.20 (s, 2H), 5.06 (s, 2H), 4.98 (s, 1H), 4.94 (s, 1H), 3.32 (d, 2H, J = 6.0 Hz), 1.70 (s, 6H); 
13
C NMR (100 MHz, CDCl3) δ 162.7, 160.5, 158.7, 156.2, 136.6, 136.2, 136.1, 128.9, 128.8, 
128.5, 128.1, 127.3, 126.9, 114.9, 109.3, 105.1, 97.8, 93.4, 71.1, 70.5, 26.9, 26.0. 
 
Compound 35 
To a solution of 16 (161 mg, 0.55 mmol) in diethyl ether : tetrahydrofuran (1:1, 10 
mL) at -78 
°
C was added n-BuLi (2.5 M solution in hexanes, 0.22 mL, 0.55 mmol). After 2 h 
at -78 
°
C, 33 (65 mg, 0.14 mmol) in tetrahydrofuran (5 mL) was added and the reaction 
mixture was warmed to 5 
°
C over 4 h. The reaction was quenched with aqueous saturated 
ammonium chloride solution and the resulting solution was diluted with diethyl ether, 
washed with water and brine, successively. The organic layer was dried over magnesium 
sulfate, filtered and evaporated in vacuo. The crude compound 34 was used directly for the 
next step without further purification. 
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To the above crude residue (34) taken up in acetone (10 mL) were added potassium 
carbonate (50 mg) and methyl iodide (0.01 mL) and the reaction mixture was heated to reflux 
for 3 h. The reaction solution was cooled to rt, passed through a pad of Celite and evaporated 
in vacuo. . The residue was purified by preparative TLC on silica gel (hexanes : ethyl acetate 
= 4:1) to afford 35 (34 mg, 39% over two steps).
 1
H NMR (400 MHz, CDCl3) δ  7.18-7.64 
(m, 15H), 7.03-7.09 (m, 2H), 6.82 (d, 1H, J = 8.4 Hz), 6.37 (s, 1H), 5.95-6.07 (m, 1H), 5.23 
(s, 2H), 5.04 (s, 2H), 4.96-5.03 (m, 2H), 4.94 (s, 2H), 3.94 (s, 3H), 3.68 (s, 3H), 3.41 (d, 2H, 
J = 5.6 Hz). 
 
Compound 38 
To a solution of 32 (100 mg, 0.18 mmol) in N,N-dimethylformamide (10 mL) were 
added 37 (0.12 mL, 0.36 mmol), dichlorobis(triphenylphosphine)-palladium(II) (26 mg, 
0.036 mmol), cesium fluoride (81 mg, 0.54 mmol) and tri(2-furyl)phosphine (13 mg, 0.054 
mmol). The reaction mixture was heated for 60 h at 100 
°
C after which it was cooled to rt, 
quenched with saturated aqueous potassium fluoride solution. The resulting solution was 
diluted with ethyl acetate, washed with water and brine, successively. The organic layer was 
dried over magnesium sulfate, filtered and evaporated in vacuo. The residue was purified by 
flash column chromatography on silica gel (hexanes : ethyl acetate = 2:1) to afford the 
prenylated compound 38 (33 mg, 37% yield).
 1
H NMR (400 MHz, CDCl3) δ 7.49-7.53 (m, 
2H), 7.30-7.41 (m, 8H), 6.23 (s, 1H), 5.19 (s, 2H), 5.11 (m, 1H), 5.04 (s, 2H), 3.25 (d, 2H, J 
= 7.2 Hz), 1.70 (s, 6H), 1.66 (s, 6H). 
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GENERAL CONCLUSIONS 
 
In this dissertation, we have explored direct routes to several biologically active 
natural products. 
 Chapter 1 describes a novel way to prepare benzoxepin core using a ring-closing 
metathesis reaction. Bauhiniastatins, which are reported to possess anti-cancer activities and 
contain benzoxepin skeleton, can thus be synthesized using this methodology. 
 Chapter 2 illustrates a short synthesis of bauhinoxepin J, which entails use of an 
environmentally benign radical reaction. This innovative intramolecular radical cyclization 
opens new avenues for constructing natural products with embeded quinone subunit. 
 Chapter 3 depicts a direct route for the synthesis of aurones and benzophenones, 
which makes use of 1,3-benzodioxin-4-ones as the key intermediate. This strategy led to 
successful synthesis of three natural products in a straightforward fashion. 
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